Patent · US Active

Anti-CD39 antibody compositions and methods

US11655303B2 · kind B2 · utility

0Cited by

62References

19Claims

0Family size

Assignee

SURFACE ONCOLOGY, LLC · US

Inventors

Scott C. Chappel · Milton, US
Andrew Lake · Cambridge, US
Michael Warren · North Chelmsford, US
Austin DULAK · Reading, US
Erik DEVEREAUX · Hanover, US
Pamela M. Holland · Seattle, US
Tauqeer ZAIDI · Sharon, US
Matthew RAUSCH · Cambridge, US
Bianka Prinz · Lebanon, US
Nels P. Nielson · Cambridge, US
Sonia DAS · Cambridge, US
Alison O'Neill · Cambridge, US

Key dates

Filing date	Sep 15, 2020
Grant date	May 23, 2023
Priority date	—
Expiry date	Oct 14, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides anti-CD39 antibody compositions and their use in treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.